Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles

Saudi Pharmaceutical Journal

Volumn 23, Issue 5, 2015, Pages 549-555

  Kumar, Lalit ^a   Sreenivasa Reddy, M ^a   Managuli, Renuka S ^a   Pai K , Girish ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Full factorial design; HPLC; Nanoparticles; Valsartan

Indexed keywords

ACETONITRILE; AMMONIUM FORMATE; NANOPARTICLE; VALSARTAN;

ACCURACY; ARTICLE; DRUG FORMULATION; FACTORIAL DESIGN; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PH; PROCESS OPTIMIZATION; ULTRAVIOLET DETECTOR;

EID: 84943585183     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2015.02.001     Document Type: Article

References (18)

1. Awotwe-Otoo D., Agarabi C., Faustin P.J., Habib M.J., Lee S., Khan M.A., Shah R.B. Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate. J. Pharmaceut. Biomed. 2012, 62:61-67.
2. Bozkir A., Saka O.M. Formulation and investigation of 5-FU nanoparticles with factorial design-based studies. II Farmaco. 2005, 60:840-846.
3. Cagigal E., González L., Alonso R.M., Jiménez R.M. PKa determination of angiotensin II receptor antagonists (ARA II) by spectroscopy. J. Pharmaceut. Biomed. 2001, 26:477-486.
4. Dolan, J. A guide to HPLC and LC-MS buffer selection. ACE HPLC Columns - ultra inert base-deactivated HPLC columns. 1-20. < (accessed on 30.10.14). http://www.ace-hplc.com.
5. Gonzalez O., Iriarte G., Ferreirós N., Maguregui M.I., Alonso R.M., Jiménez R.M. Optimization and validation of a SPE-HPLC-PDA-fluorescence method for the simultaneous determination of drug used in combined cardiovascular therapy in human plasma. J. Pharmaceut. Biomed. 2009, 50:630-639.
6. Grumbach E.S., Wagrowski-Diehl D.M., Mazzeo J.R., Alden B., Iraneta P.C. Hydrophilic interaction chromatography using silica columns for the retention of polar analytes and enhanced ESI-MS sensitivity. LC GC N. Am. 2004, 22:1010-1023.
7. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Definition of metabolic syndrome - report of the national heart, lung and blood institute/American heart association conference on scientific issues related to definition. NHLBI/AHA conference proceedings. Circulation 2004, 109:433-438.
8. ICH Harmonized Tripartite Guideline, Validation of analytical procedures: Text and Methodology Q2 (R1), International Conference on Harmonization. Geneva, Switzerland, November 2005. < (accessed on 20.12.14). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf.
9. Kearney P.M., Whelton M., Reynolds K., Maunter P., Whelton P.K., He J. Golden burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-723.
10. Nagarwal R.C., Srinatha A., Pandit J.K. In situ forming formulation: development, evaluation and optimization using factorial design. AAPS PharmSciTech. 2009, 10:977-984.
11. Rajput A.P., Sonanis M.C. Development and validation of a rapid RP-UPLC method for the determination of aspirin and dipyridamole in combined capsule formulation. Int. J. Pharm. Pharmaceut. Sci. 2011, 3:156-160.
12. Sagirli O., Önal A., Toker S.E., Sensoy D. Simultaneous HPLC analysis of olmesartan and hydrochlorothiazide in combined tablets and in vitro dissolution studies. Chromatographia 2007, 66:213-218.
13. Singh K.S., Dodge J., Durrani M.J., Khan M.A. Optimization and characterization of controlled release pellets coated with an experimental latex-I: anionic drug. Int. J. Pharm. 1995, 125:243-255.
14. Singh J., Philip A.K., Pathak K. Optimization studies on design and evaluation of orodispersible formulation of indomethacin. AAPS PharmSciTech. 2008, 9:60-66.
15. Solanki T.B., Shah P.A., Patel K.G. Central composite design for validation of HPTLC method for simultaneous estimation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in tablets. Indian J. Pharm. Sci. 2014, 76:179-187.
16. Yahiaoui I., Aissani-Benissad F. Experimental design for copper cementation process in fixed bed reactor using two-level factorial design. Arabian J. Chem. 2010, 3:187-190.
17. Yang Y.J., Song D.M., Jiang W.M., Xiang B.R. Rapid resolution RP-HPLC-DAD method for simultaneous determination of sildenafil, vardenafil and tadalafil in pharmaceutical preparations and counterfeit drugs. Anal. Lett. 2010, 43:373-380.
18. Ye C., Liu J., Ren F., Okafo N. Design of experiment and data analysis by JMP® (SAS institute) in analytical method validation. J. Pharmaceut. Biomed. 2000, 23:581-589.